Literature DB >> 21112188

A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809.

Gary Donohoe, James Walters, Derek W Morris, Andreia Da Costa, Emma Rose, April Hargreaves, Katie Maher, Eimear Hayes, Ina Giegling, Annette M Hartmann, Hans-Jürgen Möller, Pierandrea Muglia, Valentina Moskvina, Michael J Owen, Michael C O'Donovan, Michael Gill, Aiden Corvin, Dan Rujescu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21112188     DOI: 10.1016/j.schres.2010.10.019

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  9 in total

1.  The effect of neurogranin on neural correlates of episodic memory encoding and retrieval.

Authors:  Axel Krug; Sören Krach; Andreas Jansen; Vanessa Nieratschker; Stephanie H Witt; N Jon Shah; Markus M Nöthen; Marcella Rietschel; Tilo Kircher
Journal:  Schizophr Bull       Date:  2011-07-28       Impact factor: 9.306

2.  Risk variant for schizophrenia in the neurogranin gene impacts on hippocampus activation during contextual fear conditioning.

Authors:  S T Pohlack; F Nees; M Ruttorf; S H Witt; V Nieratschker; M Rietschel; H Flor
Journal:  Mol Psychiatry       Date:  2011-06-07       Impact factor: 15.992

3.  Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia.

Authors:  Kazutaka Ohi; Ryota Hashimoto; Yuka Yasuda; Kiyotaka Nemoto; Takashi Ohnishi; Motoyuki Fukumoto; Hidenaga Yamamori; Satomi Umeda-Yano; Takeya Okada; Masao Iwase; Hiroaki Kazui; Masatoshi Takeda
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

4.  Effects of the neurogranin variant rs12807809 on thalamocortical morphology in schizophrenia.

Authors:  Jamie Yu Jin Thong; Anqi Qiu; Min Yi Sum; Carissa Nadia Kuswanto; Ta Ahn Tuan; Gary Donohoe; Yih Yian Sitoh; Kang Sim
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

5.  Dissociation of accumulated genetic risk and disease severity in patients with schizophrenia.

Authors:  S Papiol; D Malzahn; A Kästner; S Sperling; M Begemann; H Stefansson; H Bickeböller; K-A Nave; H Ehrenreich
Journal:  Transl Psychiatry       Date:  2011-10-04       Impact factor: 6.222

6.  Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT).

Authors:  T Lencz; E Knowles; G Davies; S Guha; D C Liewald; J M Starr; S Djurovic; I Melle; K Sundet; A Christoforou; I Reinvang; S Mukherjee; Pamela DeRosse; A Lundervold; V M Steen; M John; T Espeseth; K Räikkönen; E Widen; A Palotie; J G Eriksson; I Giegling; B Konte; M Ikeda; P Roussos; S Giakoumaki; K E Burdick; A Payton; W Ollier; M Horan; G Donohoe; D Morris; A Corvin; M Gill; N Pendleton; N Iwata; A Darvasi; P Bitsios; D Rujescu; J Lahti; S L Hellard; M C Keller; O A Andreassen; I J Deary; D C Glahn; A K Malhotra
Journal:  Mol Psychiatry       Date:  2013-12-17       Impact factor: 15.992

7.  Comprehensive promoter level expression quantitative trait loci analysis of the human frontal lobe.

Authors:  Cornelis Blauwendraat; Margherita Francescatto; J Raphael Gibbs; Iris E Jansen; Javier Simón-Sánchez; Dena G Hernandez; Allissa A Dillman; Andrew B Singleton; Mark R Cookson; Patrizia Rizzu; Peter Heutink
Journal:  Genome Med       Date:  2016-06-10       Impact factor: 11.117

8.  Neurogranin regulates eNOS function and endothelial activation.

Authors:  Vino T Cheriyan; Mabruka Alfaidi; Ashton N Jorgensen; Md Ashiqul Alam; Chowdhury S Abdullah; Gopi K Kolluru; Md Shenuarin Bhuiyan; Christopher G Kevil; A Wayne Orr; Hyung W Nam
Journal:  Redox Biol       Date:  2020-03-05       Impact factor: 11.799

9.  The association between rs12807809 polymorphism in neurogranin gene and risk of schizophrenia: A meta-analysis.

Authors:  Lu Jin; Zhiguo An; Bin Xu; Daibin Mu; Songnian Fu; Hongxing Hu; Yongyong Shi; Xiao Luo; Qizhong Yi
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.